Mon–Thu 8am–4:30pm CT · Fri 8am–3pm CT
Clinical Trial · NCT04983459
Overview
The aim of this study is to evaluate PSMA-PET for the detection of occult biological recurrence in patients with prostatic cancer referred to the Brest University Hospital.
Sponsor
University Hospital, Brest
ClinicalTrials.gov
NCT04983459Eligibility
Help us improve your experience